APUS Scorecard | APIMEDS PHARMACEUTICALS US, INC.

APIMEDS PHARMACEUTICALS US, INC. (APUS) Scorecard

2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Win.
2026-Q1: Total return Win; Revenue growth Lose; EPS growth Win.
2025-Q4: Total return Lose; Revenue growth Lose; EPS growth Win.
2025-Q3: Total return Lose; Revenue growth Lose; EPS growth Lose.

40 QUARTERS × 3 ROAST BATTLES

4/120 All 120 Win/Lose results shown below

Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.

Trailing 1 year (4 quarters): 4 wins, 8 lossesLast fetched: 4 Sept 2026

Complete point ledger

Each cell identifies the missing side explicitly.

Quarter	Total return	Revenue growth	EPS growth
2026-Q21/3	LoseAPUS / S&P -49.69% / 15.20%	LoseAPUS / S&P APUS unavailable / 15.00%	WinAPUS / S&P 427.78% / 50.40%
2026-Q12/3	WinAPUS / S&P 9.09% / -4.33%	LoseAPUS / S&P APUS unavailable / 11.30%	WinAPUS / S&P 2557.89% / 27.70%
2025-Q41/3	LoseAPUS / S&P -7.87% / 2.65%	LoseAPUS / S&P APUS unavailable / 9.00%	WinAPUS / S&P 1477.78% / 13.40%
2025-Q30/3	LoseAPUS / S&P 1.14% / 8.12%	LoseAPUS / S&P APUS unavailable / 4.61%	LoseAPUS / S&P APUS unavailable / 13.45%
2025-Q20/3	LoseAPUS / S&P APUS unavailable / 10.94%	LoseAPUS / S&P APUS unavailable / 4.83%	LoseAPUS / S&P APUS unavailable / 10.63%
2025-Q10/3	LoseAPUS / S&P APUS unavailable / -4.27%	LoseAPUS / S&P APUS unavailable / 4.98%	LoseAPUS / S&P APUS unavailable / 10.57%
2024-Q40/3	LoseAPUS / S&P APUS unavailable / 2.41%	LoseAPUS / S&P APUS unavailable / 5.25%	LoseAPUS / S&P APUS unavailable / 6.15%
2024-Q30/3	LoseAPUS / S&P APUS unavailable / 5.89%	LoseAPUS / S&P APUS unavailable / 5.89%	LoseAPUS / S&P APUS unavailable / 6.11%
2024-Q20/3	LoseAPUS / S&P APUS unavailable / 4.28%	LoseAPUS / S&P APUS unavailable / 5.38%	LoseAPUS / S&P APUS unavailable / 5.12%
2024-Q10/3	LoseAPUS / S&P APUS unavailable / 10.56%	LoseAPUS / S&P APUS unavailable / 5.71%	LoseAPUS / S&P APUS unavailable / 5.59%
2023-Q40/3	LoseAPUS / S&P APUS unavailable / 11.69%	LoseAPUS / S&P APUS unavailable / 6.81%	LoseAPUS / S&P APUS unavailable / 7.78%
2023-Q30/3	LoseAPUS / S&P APUS unavailable / -3.27%	LoseAPUS / S&P APUS unavailable / 7.52%	LoseAPUS / S&P APUS unavailable / -5.03%
2023-Q20/3	LoseAPUS / S&P APUS unavailable / 8.74%	LoseAPUS / S&P APUS unavailable / 9.50%	LoseAPUS / S&P APUS unavailable / -8.57%
2023-Q10/3	LoseAPUS / S&P APUS unavailable / 7.50%	LoseAPUS / S&P APUS unavailable / 10.77%	LoseAPUS / S&P APUS unavailable / -15.69%
2022-Q40/3	LoseAPUS / S&P APUS unavailable / 7.56%	LoseAPUS / S&P APUS unavailable / 11.88%	LoseAPUS / S&P APUS unavailable / -17.99%
2022-Q30/3	LoseAPUS / S&P APUS unavailable / -4.88%	LoseAPUS / S&P APUS unavailable / 13.47%	LoseAPUS / S&P APUS unavailable / -1.41%
2022-Q20/3	LoseAPUS / S&P APUS unavailable / -16.10%	LoseAPUS / S&P APUS unavailable / 13.71%	LoseAPUS / S&P APUS unavailable / 11.04%
2022-Q10/3	LoseAPUS / S&P APUS unavailable / -4.60%	LoseAPUS / S&P APUS unavailable / 15.97%	LoseAPUS / S&P APUS unavailable / 42.23%
2021-Q40/3	LoseAPUS / S&P APUS unavailable / 11.03%	LoseAPUS / S&P APUS unavailable / 15.00%	LoseAPUS / S&P APUS unavailable / 96.40%
2021-Q30/3	LoseAPUS / S&P APUS unavailable / 0.58%	LoseAPUS / S&P APUS unavailable / 10.77%	LoseAPUS / S&P APUS unavailable / 69.42%
2021-Q20/3	LoseAPUS / S&P APUS unavailable / 8.55%	LoseAPUS / S&P APUS unavailable / 6.58%	LoseAPUS / S&P APUS unavailable / 51.81%
2021-Q10/3	LoseAPUS / S&P APUS unavailable / 6.17%	LoseAPUS / S&P APUS unavailable / -1.06%	LoseAPUS / S&P APUS unavailable / 7.39%
2020-Q40/3	LoseAPUS / S&P APUS unavailable / 12.15%	LoseAPUS / S&P APUS unavailable / -3.72%	LoseAPUS / S&P APUS unavailable / -33.42%
2020-Q30/3	LoseAPUS / S&P APUS unavailable / 8.93%	LoseAPUS / S&P APUS unavailable / -2.04%	LoseAPUS / S&P APUS unavailable / -27.10%
2020-Q20/3	LoseAPUS / S&P APUS unavailable / 20.54%	LoseAPUS / S&P APUS unavailable / -0.46%	LoseAPUS / S&P APUS unavailable / -27.11%
2020-Q10/3	LoseAPUS / S&P APUS unavailable / -19.60%	LoseAPUS / S&P APUS unavailable / 3.47%	LoseAPUS / S&P APUS unavailable / -14.75%
2019-Q40/3	LoseAPUS / S&P APUS unavailable / 9.07%	LoseAPUS / S&P APUS unavailable / 5.36%	LoseAPUS / S&P APUS unavailable / 2.99%
2019-Q30/3	LoseAPUS / S&P APUS unavailable / 1.70%	LoseAPUS / S&P APUS unavailable / 5.02%	LoseAPUS / S&P APUS unavailable / 0.21%
2019-Q20/3	LoseAPUS / S&P APUS unavailable / 4.30%	LoseAPUS / S&P APUS unavailable / 6.64%	LoseAPUS / S&P APUS unavailable / 8.65%
2019-Q10/3	LoseAPUS / S&P APUS unavailable / 13.65%	LoseAPUS / S&P APUS unavailable / 8.12%	LoseAPUS / S&P APUS unavailable / 14.29%
2018-Q40/3	LoseAPUS / S&P APUS unavailable / -13.52%	LoseAPUS / S&P APUS unavailable / 9.05%	LoseAPUS / S&P APUS unavailable / 18.23%
2018-Q30/3	LoseAPUS / S&P APUS unavailable / 7.71%	LoseAPUS / S&P APUS unavailable / 10.21%	LoseAPUS / S&P APUS unavailable / 19.06%
2018-Q20/3	LoseAPUS / S&P APUS unavailable / 3.43%	LoseAPUS / S&P APUS unavailable / 9.03%	LoseAPUS / S&P APUS unavailable / 14.46%
2018-Q10/3	LoseAPUS / S&P APUS unavailable / -0.76%	LoseAPUS / S&P APUS unavailable / 7.68%	LoseAPUS / S&P APUS unavailable / 12.46%
2017-Q40/3	LoseAPUS / S&P APUS unavailable / 6.64%	LoseAPUS / S&P APUS unavailable / 7.03%	LoseAPUS / S&P APUS unavailable / 13.82%
2017-Q30/3	LoseAPUS / S&P APUS unavailable / 4.48%	LoseAPUS / S&P APUS unavailable / 5.68%	LoseAPUS / S&P APUS unavailable / 17.57%
2017-Q20/3	LoseAPUS / S&P APUS unavailable / 3.09%	LoseAPUS / S&P APUS unavailable / 4.83%	LoseAPUS / S&P APUS unavailable / 17.74%
2017-Q10/3	LoseAPUS / S&P APUS unavailable / 6.07%	LoseAPUS / S&P APUS unavailable / 3.67%	LoseAPUS / S&P APUS unavailable / 13.32%
2016-Q40/3	LoseAPUS / S&P APUS unavailable / 3.82%	LoseAPUS / S&P APUS unavailable / 2.09%	LoseAPUS / S&P APUS unavailable / 7.05%
2016-Q30/3	LoseAPUS / S&P APUS unavailable / 3.85%	LoseAPUS / S&P APUS unavailable / 0.20%	LoseAPUS / S&P APUS unavailable / -3.15%

Dividend-reinvested, split-adjusted total return

1Y · 2025-08-29 to 2026-08-27

Metric	APUS total return	S&P 500 Total Return Index
Total return	-78.42%	20.78%
Annualized return	-78.42%	20.78%

5Y · 2025-05-09 to 2026-08-27

Metric	APUS total return	S&P 500 Total Return Index
Total return	-82.05%	83.14%
Annualized return	-29.07%	12.86%

10Y · 2025-05-09 to 2026-08-27

Metric	APUS total return	S&P 500 Total Return Index
Total return	-82.05%	319.30%
Annualized return	-15.78%	15.41%

Calculation rules

window: Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
return Basis: Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
point Rule: Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
frequency: Quarter endpoints only.
fundamentals: Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
non Scoring

Snapshot captured 2026-09-04.

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
InMed Pharmaceuticals Inc. (INM)		$0.008B	-0.65
Ensysce Biosciences, Inc. (ENSC)	United States	$0.008B	-0.37
CNS Pharmaceuticals, Inc. (CNSP)	United States	$0.007B
EXICURE, INC. (XCUR)	United States	$0.008B	-1.54
Acurx Pharmaceuticals, Inc. (ACXP)	United States	$0.007B	-0.97
SYNLOGIC, INC. (SYBX)	United States	$0.007B
SOLIGENIX, INC. (SNGX)	United States	$0.008B
Imunon, Inc. (IMNN)	United States	$0.008B	-0.56
Bolt Biotherapeutics, Inc. (BOLT)	United States	$0.007B	-0.26
Enveric Biosciences, Inc. (ENVB)	United States	$0.007B	-0.63